Evaluating the treatment and control of modifiable cardiovascular disease risk factors among patients with diabetes in the Inner Mongolia, China: A cross-sectional study
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Preventive Medicine
- Vol. 139, 106174
Abstract
No abstract availableKeywords
Funding Information
- National Health and Family Planning Commission of the People's Republic of China
This publication has 35 references indexed in Scilit:
- Prevalence and Control of Diabetes in Chinese AdultsJAMA, 2013
- Management of diabetes mellitus and associated cardiovascular risk factors in Brazil – the Brazilian study on the practice of diabetes careDiabetology & Metabolic Syndrome, 2013
- Younger adult type 2 diabetic patients have poorer glycaemic control: a cross-sectional study in a primary care setting in SingaporeBMC Endocrine Disorders, 2013
- Managing diabetes in Asia: Overcoming obstacles and the role of DPP-IV inhibitorsDiabetes Research and Clinical Practice, 2012
- Moving towards universal health insurance in China: Performance, issues and lessons from ThailandSocial Science & Medicine, 2011
- Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trialsDiabetes Research and Clinical Practice, 2009
- Standardisation of rates using logistic regression: a comparison with the direct methodBMC Health Services Research, 2008
- Cardiovascular risk factor control among diabetic patients attending community-based diabetic care clinics in ItalyDiabetes Research and Clinical Practice, 2007
- The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes MellitusAnnals of Internal Medicine, 2003
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998